DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,228,250 | +3.6% | 198,421 | +0.2% | 0.42% | +8.3% |
| Q2 2023 | $47,517,840 | -0.2% | 197,991 | +4.9% | 0.39% | -9.6% |
| Q1 2023 | $47,591,705 | -4.8% | 188,826 | +0.3% | 0.43% | -11.6% |
| Q4 2022 | $49,978,055 | +3.1% | 188,298 | +0.3% | 0.48% | -3.8% |
| Q3 2022 | $48,495,000 | +2.6% | 187,756 | +0.7% | 0.50% | +9.4% |
| Q2 2022 | $47,267,000 | -8.7% | 186,441 | +5.6% | 0.46% | +10.1% |
| Q1 2022 | $51,764,000 | -10.6% | 176,471 | +0.3% | 0.42% | -5.4% |
| Q4 2021 | $57,896,000 | +6.2% | 175,971 | -1.7% | 0.44% | -0.9% |
| Q3 2021 | $54,500,000 | +13.1% | 179,016 | -0.3% | 0.44% | +13.5% |
| Q2 2021 | $48,194,000 | +18.8% | 179,588 | -0.3% | 0.39% | +10.7% |
| Q1 2021 | $40,552,000 | -0.9% | 180,168 | -2.2% | 0.35% | -4.6% |
| Q4 2020 | $40,923,000 | -2.0% | 184,221 | -5.0% | 0.37% | -10.6% |
| Q3 2020 | $41,754,000 | +60.4% | 193,909 | +31.7% | 0.42% | +13.1% |
| Q2 2020 | $26,029,000 | +22.5% | 147,196 | -4.2% | 0.37% | +0.5% |
| Q1 2020 | $21,256,000 | -9.5% | 153,576 | +0.4% | 0.36% | +29.0% |
| Q4 2019 | $23,478,000 | +6.8% | 152,974 | +0.5% | 0.28% | +5.6% |
| Q3 2019 | $21,982,000 | +0.2% | 152,198 | -0.8% | 0.27% | +5.5% |
| Q2 2019 | $21,928,000 | +3.0% | 153,427 | -4.8% | 0.25% | +0.4% |
| Q1 2019 | $21,287,000 | +22.0% | 161,242 | -4.7% | 0.25% | +12.9% |
| Q4 2018 | $17,442,000 | -22.8% | 169,141 | -18.6% | 0.22% | +5.2% |
| Q3 2018 | $22,586,000 | +11.7% | 207,863 | +1.5% | 0.21% | +4.9% |
| Q2 2018 | $20,217,000 | +0.1% | 204,871 | -0.7% | 0.20% | -0.5% |
| Q1 2018 | $20,205,000 | +2.8% | 206,363 | -2.5% | 0.20% | +6.8% |
| Q4 2017 | $19,647,000 | +10.7% | 211,663 | +2.3% | 0.19% | -9.9% |
| Q3 2017 | $17,740,000 | +7.6% | 206,813 | +5.9% | 0.21% | -7.0% |
| Q2 2017 | $16,487,000 | -4.1% | 195,368 | -2.8% | 0.23% | -5.4% |
| Q1 2017 | $17,189,000 | +10.3% | 200,968 | +0.3% | 0.24% | +5.2% |
| Q4 2016 | $15,589,000 | +18.4% | 200,268 | +19.2% | 0.23% | +14.5% |
| Q3 2016 | $13,167,000 | -21.1% | 167,968 | +1.7% | 0.20% | -14.5% |
| Q2 2016 | $16,682,000 | +6.6% | 165,168 | +0.1% | 0.23% | +14.7% |
| Q1 2016 | $15,649,000 | +2.4% | 164,968 | +0.3% | 0.20% | +0.5% |
| Q4 2015 | $15,276,000 | +10.2% | 164,468 | +1.1% | 0.20% | +4.6% |
| Q3 2015 | $13,861,000 | -5.5% | 162,668 | -4.9% | 0.19% | +12.1% |
| Q4 2014 | $14,662,000 | +13.7% | 171,068 | +0.8% | 0.17% | +8.1% |
| Q3 2014 | $12,891,000 | -4.2% | 169,668 | -0.7% | 0.16% | -1.8% |
| Q2 2014 | $13,452,000 | +7.2% | 170,868 | +2.1% | 0.16% | +2.5% |
| Q1 2014 | $12,552,000 | -5.2% | 167,368 | -2.4% | 0.16% | -2.5% |
| Q4 2013 | $13,237,000 | +8.6% | 171,468 | -2.4% | 0.16% | +4.5% |
| Q3 2013 | $12,184,000 | +14.3% | 175,768 | +4.4% | 0.16% | +7.6% |
| Q2 2013 | $10,657,000 | -0.5% | 168,368 | -2.3% | 0.14% | -5.2% |
| Q1 2013 | $10,712,000 | – | 172,368 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |